Featured, News, Trade Ideas

Novo Nordisk Soars on Promising Results for New Weight Loss Drug

January 24, 2025 No comments yet

Novo Nordisk’s (NYSE: NVO) stock surged over 12% in pre-market trading Friday after the company announced favorable early-stage clinical trial results for its latest weight loss drug, amycretin. The once-weekly injection, similar to Novo’s blockbuster drugs Wegovy and Ozempic, demonstrated up to 22% weight loss over 36 weeks in a trial involving 125 participants. The […]

Featured, News, Trade Ideas

European Markets Open Higher Amid Holiday Week, Novo Nordisk Rebounds

December 23, 2024 No comments yet

Markets Begin Festive Week on a Positive Note as Novo Nordisk Recovers From Friday’s Plunge European markets started the week on a positive trajectory, with the pan-European Stoxx 600 index gaining 0.4% in early Monday trading. Most sectors posted gains as investors settled into a shortened trading week ahead of the Christmas holiday. Positive Momentum […]